.png){kind=icon}
返回
Prostate Cancer Early Detection, Version 2.2016
.png){kind=icon}
OA
AI
DOI：10.6004/jnccn.2016.0060.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer Early Detection provide recommendations for prostate cancer screening in healthy men who have elected to participate in an early detection program. The NCCN Guidelines focus on minimizing unnecessary procedures and limiting the detection of indolent disease. These NCCN Guidelines Insights summarize the NCCN Prostate Cancer Early Detection Panel's most significant discussions for the 2016 guideline update, which included issues surrounding screening in high-risk populations (ie, African Americans, BRCA1/2 mutation carriers), approaches to refine patient selection for initial and repeat biopsies, and approaches to improve biopsy specificity.
Keyword:
HEALTH INDEX PHI
ULTRASOUND-GUIDED BIOPSY
BRCA2 MUTATION CARRIERS
AFRICAN-AMERICAN MEN
FAMILY-HISTORY
RANDOMIZED PROSTATE
DIAGNOSTIC-ACCURACY
BREAST-CANCER
URINARY PCA3
GENE 3
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
J
IF:
16.4
论文数:
2.8K
被引数:
1.5W
机构
查看更多机构
引用论文
暂无论文信息